2,3-Dihydroxy-7-sulphamoyl-benzo[f]quinoxaline

CAS: 118876-57-6

Ref. 3D-FD22092

Produktinformation

• Name: 2,3-Dihydroxy-7-sulphamoyl-benzo[f]quinoxaline
• Synonyme: 1,2,3,4-Tetrahydro-2,3-dioxo-benzo[f]quinoxaline-7-sulfonamide, Bqx-cpd, Benzo(f)quinoxaline-7-sulfonamide, 1,2,3,4-tetrahydro-2,3-dioxo-, 2,3-Dioxo-1,2,3,4-Tetrahydrobenzo[F]Quinoxaline-7-Sulfonamide

Beschreibung

2,3-Dihydroxy-7-sulphamoyl-benzo[f]quinoxaline is a receptor antagonist that blocks the activation of ionotropic receptors in the nervous system. It is a potent and selective blocker of acid receptors, which are G protein coupled receptors (GPCRs) activated by extracellular protons. 2,3-Dihydroxy-7-sulphamoyl-benzo[f]quinoxaline has been shown to block synaptic transmission mediated by acid receptors. This drug can be used to study the pathogenesis of neurodegenerative disorders such as Alzheimer's disease and Parkinson's disease.

• Marke: Biosynth

Chemische Eigenschaften

• Molekulargewicht: 291.28 g/mol
• Formel: C₁₂H₉N₃O₄S
• Reinheit: Min. 95%
• InChl: InChI=1S/C12H9N3O4S/c13-20(18,19)9-3-1-2-7-6(9)4-5-8-10(7)15-12(17)11(16)14-8/h1-5H,(H,14,16)(H,15,17)(H2,13,18,19)
• InChI Key: InChIKey=WMMJNDRCLVWVIF-UHFFFAOYSA-N
• SMILES: NS(=O)(=O)c1cccc2c1ccc1[nH]c(=O)c(=O)[nH]c12